Course of oral lichen planus: a retrospective study of 808 northern Italian patients

Oral Dis. 2009 Apr;15(3):235-43. doi: 10.1111/j.1601-0825.2009.01516.x. Epub 2009 Feb 16.

Abstract

Objectives: To undertake a retrospective inspection of the general features, clinical presentation and outcome of 808 Italian patients with oral lichen planus (OLP), followed up from 6 months to 17 years.

Results: The mean age was 61 years for women (n = 493) and 58 years for men (n = 315). More than 20% of the total cases had liver abnormalities (n = 164) of which 83.5% infected with hepatitis C virus (n = 137). The reticular and plaque form were the predominant type, affecting almost 60% of patients. 12.3% of patients had also extraoral manifestation, taking into account the skin (n = 63) and genital (n = 24). Symptoms were present in 40% of the total patients. Only less than 2.47% of patients underwent remission, whereas 78% still had oral lesions at the end of the follow-up period. Treatment was directed towards almost 42% of the patients, mainly using topical corticosteroids. Oral squamous cell carcinoma developed in 15 patients, commonly arising on the lateral border of the tongue.

Conclusion: This is one of the largest groups of OLP patients with such long a follow-up ever reported. We confirm the chronic nature of this disorder, rarely remissive and the treatment intend for alleviating symptoms. OLP is established to be a disease with small frequency of malignant transformation.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Carcinoma, Squamous Cell / complications
  • Carcinoma, Squamous Cell / pathology*
  • Chronic Disease
  • Female
  • Humans
  • Lichen Planus, Oral / classification
  • Lichen Planus, Oral / complications
  • Lichen Planus, Oral / pathology*
  • Lichen Planus, Oral / therapy
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Mouth Diseases / classification
  • Mouth Diseases / complications
  • Mouth Diseases / pathology
  • Mouth Neoplasms / complications
  • Mouth Neoplasms / pathology*
  • Precancerous Conditions / pathology*
  • Retrospective Studies
  • Risk Assessment

Substances

  • Adrenal Cortex Hormones